Efficacy and safety of anagliptin added to metformin and empagliflozin 25 mg in patients with type 2 diabetes: a 24-week randomized, double-blind, placebo-controlled phase 3 trial with 28-week open-label extension.
Saved in:
| Title: | Efficacy and safety of anagliptin added to metformin and empagliflozin 25 mg in patients with type 2 diabetes: a 24-week randomized, double-blind, placebo-controlled phase 3 trial with 28-week open-label extension. |
|---|---|
| Authors: | Moon JS; Division of Endocrinology and Metabolism, Department of Internal Medicine, Yeungnam University College of Medicine, Daegu, South Korea., Han KA; Division of Endocrinology and Metabolism, Department of Internal Medicine, Nowon Eulji Medical Center, Eulji University, Seoul, South Korea., Yu JM; Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, College of Medicine, Hallym University, Seoul, South Korea., Won JC; Division of Endocrinology and Metabolism, Department of Internal Medicine, Gimpo Woori Hospital, Gimpo, South Korea., Kang JG; Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, South Korea., Park S; JW Pharmaceutical Corporation, Gwacheon-si, Gyeonggi-do, South Korea., Park CY; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea. Electronic address: cydoctor@skku.edu. |
| Source: | Diabetes research and clinical practice [Diabetes Res Clin Pract] 2026 Jun; Vol. 236, pp. 113272. Date of Electronic Publication: 2026 Apr 24. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study |
| Journal Info: | Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8508335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8227 (Electronic) Linking ISSN: 01688227 NLM ISO Abbreviation: Diabetes Res Clin Pract Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1872-8227 |
|---|---|
| DOI: | 10.1016/j.diabres.2026.113272 |
